Biopsy study to learn about mesothelioma and related cancers
Part of Blood & lymphatic, Cancer, Digestive system, Hormones & metabolism, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study collects tissue samples (biopsies) and health information to better understand malignant mesothelioma and certain related solid tumors that may produce a protein called mesothelin. It may help future research and treatments, and you can only join if your diagnosis is confirmed and it’s safe for you to have the tissue taken.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 2 years old and have malignant mesothelioma, or you are 18+ with certain related cancers that may make mesothelin
- Your cancer diagnosis is confirmed by pathology (lab tissue/cell testing)
- You are able and willing to sign informed consent (or have a legal guardian consent if applicable)
- It must be medically safe for you to have a biopsy (no major unstable heart or lung problems, for example)
- You are not currently pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects tissue samples from people having surgery for pleural mesothelioma (a rare lung cancer) or other lung diseases. The samples are used to better understand the disease and improve future treatments.
This study collects tissue samples (from the lining around the lung) from adults with malignant pleural mesothelioma. Researchers will use these samples to check whether certain test markers can predict how the disease may behave, which could guide treatment decisions in the future.
This study looks at the genetic changes (molecular analysis) in certain cancers of the chest. It may help doctors learn more about what drives these cancers and how they might be diagnosed or treated in the future.
This trial tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy helps people with malignant mesothelioma live longer and feel better. It's for patients who can't have surgery or radiation, and it may be an option if you haven't had treatment before or have had limited prior treatment.
This study collects medical information from people with suspected or confirmed thoracic cancer. The goal is to learn more about these cancers and improve future care.
This study collects blood, urine, and tissue samples from people with lung, esophageal, or other chest cancers to look at cell changes. It does not test a new treatment—instead, it aims to better understand these cancers through research.
Hear when a new Thymoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.